Abstract:The thermo- and pain-sensitive Transient Receptor Potential Melastatin 3 and 8 (TRPM3 and TRPM8) ion channels are functionally associated in the lipid rafts of the plasma membrane. We have already described that cholesterol and sphingomyelin depletion, or inhibition of sphingolipid biosynthesis decreased the TRPM8 but not the TRPM3 channel opening on cultured sensory neurons. We aimed to test the effects of lipid raft disruptors on channel activation on TRPM3- and TRPM8-expressing HEK293T cells in vitro, as well as their potential analgesic actions in TRPM3 and TRPM8 channel activation involving acute pain models in mice. CHO cell viability was examined after lipid raft disruptor treatments and their effects on channel activation on channel expressing HEK293T cells by measurement of cytoplasmic Ca2+ concentration were monitored. The effects of treatments were investigated in Pregnenolone-Sulphate-CIM-0216-evoked and icilin-induced acute nocifensive pain models in mice. Cholesterol depletion decreased CHO cell viability. Sphingomyelinase and methyl-beta-cyclodextrin reduced the duration of icilin-evoked nocifensive behavior, while lipid raft disruptors did not inhibit the activity of recombinant TRPM3 and TRPM8. We conclude that depletion of sphingomyelin or cholesterol from rafts can modulate the function of native TRPM8 receptors. Furthermore, sphingolipid cleavage provided superiority over cholesterol depletion, and this method can open novel possibilities in the management of different pain conditions.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of lipid raft disruption on the activation of transient receptor potential melastatin 3 and 8 (TRPM3 and TRPM8) ion channels, and whether these effects can be used to relieve acute pain. Specifically, the researchers hope to use lipid raft - disrupting agents such as sphingomyelinase and methyl - beta - cyclodextrin (MCD) to regulate the functions of TRPM8 and TRPM3, thereby achieving analgesic effects. ### Research Background TRPM3 and TRPM8 are ion channels related to heat sensitivity and pain regulation. They are functionally related in the lipid raft regions of cell membranes. Previous studies have shown that the depletion of cholesterol and sphingomyelin or the inhibition of sphingolipid biosynthesis can reduce the opening of the TRPM8 channel, but has no significant effect on TRPM3. Therefore, this study aims to further explore the in vitro effects of lipid raft - disrupting agents on TRPM3 - and TRPM8 - expressing cells and their potential analgesic effects in mouse acute pain models. ### Research Methods 1. **Cell Viability Assay**: The survival rate of CHO cells after treatment with different concentrations of lipid raft - disrupting agents was determined by the CellTiter - Glo® luminescence method. 2. **Calcium Ion Concentration Measurement**: The changes in cytoplasmic Ca²⁺ concentration in HEK293T cells were measured using the Fura - 2 AM fluorescent Ca²⁺ - indicating dye. 3. **Acute Pain Models**: - The analgesic effects of sphingomyelinase and MCD were evaluated using the icilin - induced mouse acute pain model. - The analgesic effects of the C1 compound were evaluated using the Pregnenolone - Sulphate - CIM - 0216 - mixture - induced mouse acute pain model. ### Main Findings 1. **Effects of Lipid Raft - Disrupting Agents on Cell Viability**: - After treatment with sphingomyelinase and Myr, the survival rate of CHO cells was not affected. - After treatment with MCD and C1, the survival rate of CHO cells decreased significantly, especially with high - concentration MCD treatment. 2. **Effects of Lipid Raft - Disrupting Agents on Acute Pain Behavior**: - Sphingomyelinase and MCD significantly reduced the pain reaction time induced by icilin. - C1 treatment failed to significantly change the pain reaction time induced by PS and CIM - 0216. 3. **Effects of Lipid Raft - Disrupting Agents on the Activity of Recombinant TRPM3 and TRPM8**: - Lipid raft - disrupting agents failed to inhibit the activity of recombinant TRPM3 and TRPM8, indicating that over - expressed ion channels may have different regulatory mechanisms from native receptors. ### Conclusions The research results show that sphingomyelinase and MCD can regulate the function of TRPM8 by disrupting lipid rafts and exhibit certain analgesic effects in vivo. In contrast, the effect of cholesterol depletion is not as obvious as sphingomyelin hydrolysis. In addition, lipid raft - disrupting agents have a smaller impact on over - expressed TRPM3 and TRPM8, suggesting that their role in the natural cell environment is more important. In summary, this study provides new ideas for the development of new analgesic drugs, especially by targeting lipid rafts to regulate the function of TRPM8.

Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model

Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation

Antinociceptive Effects of Lipid Raft Disruptors, a Novel Carboxamido-Steroid and Methyl β-Cyclodextrin, in Mice by Inhibiting Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Channel Activation

Lipid raft disruption inhibits the activation of Transient Receptor Potential Vanilloid 1, but not TRP Melastatin 3 and the voltage-gated L-type calcium channels in sensory neurons

Characterization of New TRPM8 Modulators in Pain Perception

Cyclodextrin derivatives decrease Transient Receptor Potential vanilloid 1 and Ankyrin 1 ion channel activation via altering the surrounding membrane microenvironment by cholesterol depletion

Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice

Analgesic effects of the novel semicarbazide-sensitive amine oxidase inhibitor SZV 1287 in mouse pain models with neuropathic mechanisms: Involvement of transient receptor potential vanilloid 1 and ankyrin 1 receptors

The Analgesic Effects of (5R,6R)6-(3-Propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1] Octane on a Mouse Model of Neuropathic Pain.

Antinociception of Spirocyclopiperazinium Salt Compound LXM-10-M Targeting Α7 Nicotinic Receptor and M4 Muscarinic Receptor and Inhibiting CaMKIIα/CREB/CGRP Signaling Pathway in Mice

CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain

Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model

Inflammatory pain resolution by mouse serum-derived small extracellular vesicles

Alleviation of behavioral hypersensitivity in mouse models of inflammatory pain with two structurally different casein kinase 1 (CK1) inhibitors

Antinociception of the Spirocyclopiperazinium Salt Compound LXM-15 Via Activating Α7 Nachr and M4 Machr and Inhibiting CaMKIIα/cAMP/CREB/CGRP Signalling Pathway in Mice.

Therapeutic Effects of Combined Treatment with the AEA Hydrolysis Inhibitor PF04457845 and the Substrate Selective COX-2 Inhibitor LM4131 in the Mouse Model of Neuropathic Pain

Synthetic chalcones as potential tool for acute- and chronic-pain control

Analgesic effects of the CTK 01512-2 toxin in different models of orofacial pain in rats

Differential contribution of sensory transient receptor potential channels in response to the bioactive lipid sphingosine-1-phosphate

Antiallodynic action of phosphodiesterase inhibitors in a mouse model of peripheral nerve injury

Discovery of Novel TRPM8 Blockers Suitable for the Treatment of Somatic and Ocular Painful Conditions: A Journey through p Ka and LogD Modulation